AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
HSIC Stock Rises Amid Expanded Partnership with vVARDIS for Drill-Free Dental Product Curodont
ByAinvest
Tuesday, Dec 2, 2025 9:47 am ET1min read
Henry Schein, Inc. HSIC expanded its agreement with vVARDIS, gaining exclusive U.S. distribution rights for Curodont, a drill-free cavity treatment. The partnership is expected to bolster the company's Dental business, with HSIC shares rising 0.1% after the announcement. The company's revenue growth is supported by niche acquisitions and partnerships. Curodont is a proprietary solution that treats early-stage cavities with a drill and needle-free application, with the potential to address up to 80% of untreated cavities in patients. The global dental caries treatment market is predicted to increase from $8.01 billion in 2025 to approximately $12.11 billion by 2034, at a CAGR of 4.70% during 2025-2034.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet